Insights on the Diabetes Devices and Drugs Global Market to 2026 - Rapidly Changing Lifestyles are Driving Growth

Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Diabetes Devices and Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.

The report on the global diabetes devices and drugs market provides qualitative and quantitative analysis for the period from 2018 to 2026. The report predicts the global diabetes devices and drugs market to grow with a CAGR of 6.5% over the forecast period from 2020-2026. The study on diabetes devices and drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.

The report on diabetes devices and drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global diabetes devices and drugs market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global diabetes devices and drugs market over the period of 2018 to 2026. Further, the Publisher's Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

• The growing prevalence of diabetes due to population growth, aging, and urbanization

• The rapidly changing lifestyles

• Raising awareness about diabetes and diabetes management among patients

2) Restraints

• Low awareness about diabetes management and monitoring devices in under-developed countries

3) Opportunities

• Ongoing technological advancements and the introduction of advanced insulin delivery devices

Segment Covered

The global diabetes devices and drugs market is segmented on the basis of type, and end user.

The Global Diabetes Devices and Drugs Market by Type

• Devices

• Continuous Blood Glucose Monitoring Devices

• Test Strips

• Lancets

• Self-monitoring Devices

• Insulin Pens

• Insulin Pumps

• Others

• Drugs

• Insulin

• Oral Hypoglycaemic Agents

• Non-Insulin Injectable

The Global Diabetes Devices and Drugs Market by End User

• Hospitals

• Clinics

• Ambulatory Surgical Centers

• Home Care Centers

• Self-Care

Company Profiles

The companies covered in the report include

• Novo Nordisk A/S

• Ypsomed AG

• Abbott Laboratories

• Ascensia Diabetes Care Holdings AG

• Eli Lilly and Company

• Hoffmann-La Roche Ltd.

• Johnson & Johnson

• Medtronic PLC

• Becton, Dickinson and Company

• Terumo Corporation

What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the diabetes devices and drugs market.
2. Complete coverage of all the segments in the diabetes devices and drugs market to analyze the trends, developments in the global market and forecast of market size up to 2026.
3. Comprehensive analysis of the companies operating in the global diabetes devices and drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. The Publisher's Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Global Diabetes Devices and Drugs Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Diabetes Devices and Drugs Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Type
3.5.2. Growth Matrix Analysis by End User
3.5.3. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Diabetes Devices and Drugs Market

4. Diabetes Devices and Drugs Market Macro Indicator Analysis

5. Global Diabetes Devices and Drugs Market by Type
5.1. Devices
5.1.1. Continuous Blood Glucose Monitoring Devices
5.1.2. Test Strips
5.1.3. Lancets
5.1.4. Self-monitoring Devices
5.1.5. Insulin Pens
5.1.6. Insulin Pumps
5.1.7. Others
5.2. Drugs
5.2.1. Insulin
5.2.2. Oral Hypoglycaemic Agents
5.2.3. Non-Insulin Injectable

6. Global Diabetes Devices and Drugs Market by End User
6.1. Hospitals
6.2. Clinics
6.3. Ambulatory Surgical Centers
6.4. Home Care Centers
6.5. Self-Care

7. Global Diabetes Devices and Drugs Market by Region 2020-2026
7.1. North America
7.1.1. North America Diabetes Devices and Drugs Market by Type
7.1.2. North America Diabetes Devices and Drugs Market by End User
7.1.3. North America Diabetes Devices and Drugs Market by Country
7.2. Europe
7.2.1. Europe Diabetes Devices and Drugs Market by Type
7.2.2. Europe Diabetes Devices and Drugs Market by End User
7.2.3. Europe Diabetes Devices and Drugs Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Diabetes Devices and Drugs Market by Type
7.3.2. Asia-Pacific Diabetes Devices and Drugs Market by End User
7.3.3. Asia-Pacific Diabetes Devices and Drugs Market by Country
7.4. RoW
7.4.1. RoW Diabetes Devices and Drugs Market by Type
7.4.2. RoW Diabetes Devices and Drugs Market by End User
7.4.3. RoW Diabetes Devices and Drugs Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Diabetes Devices and Drugs Market
8.2. Companies Profiled
8.2.1. Novo Nordisk A/S
8.2.2. Ypsomed AG
8.2.3. Abbott Laboratories
8.2.4. Ascensia Diabetes Care Holdings AG
8.2.5. Eli Lilly and Company
8.2.6. Hoffmann-La Roche Ltd.
8.2.7. Johnson & Johnson
8.2.8. Medtronic PLC
8.2.9. Becton, Dickinson and Company
8.2.10. Terumo Corporation

For more information about this report visit https://www.researchandmarkets.com/r/vixq4v

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900